FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2573039196> ?p ?o ?g. }

• W2573039196 abstract "Abstract In this study we tested the efficacy of a test dose of iv busulfan in targeting blood levels of this drug during the conditioning regimen prior to an allogeneic hematopoietic stem cell transplant. We analyzed blood samples of 22 patients undergoing allogeneic hematopoietic stem cell transplantation with a busulfan-based conditioning regimen. Patients received a test dose of busulfan at 0.8 mg/kg as a 60 minute intravenous infusion. Serial blood samples were drawn at eight time points: 15 minutes before dose, at end of infusion, 15 minutes after completion, 30 minutes after completion, 60 minutes after completion, 2 hours after completion, 4 hours after completion, and 6 hours after completion. Pharmacokinetics (PK) studies were then performed at the Seattle Cancer Care pharmacokinetics laboratory. The AUC was determined using WinNonlin Professional software. The conditioning dose of busulfan was calculated by multiplying the test dose in mg/AUC × 4800. After the first dose of busulfan was administered, the same protocol was used to test busulfan PK. If the Busulfan AUC was therapeutic (between 4800 μM*min and 5200 μM*min) then the same dose was continued. If the Busulfan AUC was low or high then the third and fourth doses of busulfan were adjusted. The test dose of 0.8 mg/kg intravenous did not have any hematological side effects. The mean historic dose (solely based on weight) was 3.2 ± 0.1 mg/kg and the mean dose based on the test dose was 3.5 ± 0.5 mg/kg (p=0.02). In 12 patients where we also analyzed PK after the first day of conditioning regimen, AUC values of busulfan obtained during test dose and after day 1 dose were not different (p=0.7). The mean dose of busulfan based on test dose was 3.5 ± 0.6 mg/kg while the final dose based on day 1 busulfan PK was 3.6 ± 0.7 mg/kg (p=0.9). Nevertheless, in 2 CML patients who were on treatment with dasatinib or nilotinib at the time of the test dose, a higher AUC was observed (AUC 6065 and 6200, respectively). A pre-transplant busulfan test dose can be safely performed anytime prior to transplant and allows targeting the dose of busulfan efficiently, thus avoiding the requirement of PK studies during the conditioning regimen." @default.
• W2573039196 created "2017-01-26" @default.
• W2573039196 creator A5004258873 @default.
• W2573039196 creator A5029836748 @default.
• W2573039196 creator A5030322700 @default.
• W2573039196 creator A5039871228 @default.
• W2573039196 creator A5055431983 @default.
• W2573039196 creator A5055963753 @default.
• W2573039196 creator A5065397717 @default.
• W2573039196 creator A5069148808 @default.
• W2573039196 creator A5082073230 @default.
• W2573039196 date "2007-11-16" @default.
• W2573039196 modified "2023-09-26" @default.
• W2573039196 title "Pre-Transplant Test Dose vs. PK Studies during Conditioning Regimen To Target iv Busulfan in Allogeneic Hematopoietic Stem Cell Transplantation." @default.
• W2573039196 doi "https://doi.org/10.1182/blood.v110.11.3006.3006" @default.
• W2573039196 hasPublicationYear "2007" @default.
• W2573039196 type Work @default.
• W2573039196 sameAs 2573039196 @default.
• W2573039196 citedByCount "0" @default.
• W2573039196 crossrefType "journal-article" @default.
• W2573039196 hasAuthorship W2573039196A5004258873 @default.
• W2573039196 hasAuthorship W2573039196A5029836748 @default.
• W2573039196 hasAuthorship W2573039196A5030322700 @default.
• W2573039196 hasAuthorship W2573039196A5039871228 @default.
• W2573039196 hasAuthorship W2573039196A5055431983 @default.
• W2573039196 hasAuthorship W2573039196A5055963753 @default.
• W2573039196 hasAuthorship W2573039196A5065397717 @default.
• W2573039196 hasAuthorship W2573039196A5069148808 @default.
• W2573039196 hasAuthorship W2573039196A5082073230 @default.
• W2573039196 hasConcept C112705442 @default.
• W2573039196 hasConcept C141071460 @default.
• W2573039196 hasConcept C2777408962 @default.
• W2573039196 hasConcept C2780611847 @default.
• W2573039196 hasConcept C2781413609 @default.
• W2573039196 hasConcept C2911091166 @default.
• W2573039196 hasConcept C71924100 @default.
• W2573039196 hasConcept C98274493 @default.
• W2573039196 hasConceptScore W2573039196C112705442 @default.
• W2573039196 hasConceptScore W2573039196C141071460 @default.
• W2573039196 hasConceptScore W2573039196C2777408962 @default.
• W2573039196 hasConceptScore W2573039196C2780611847 @default.
• W2573039196 hasConceptScore W2573039196C2781413609 @default.
• W2573039196 hasConceptScore W2573039196C2911091166 @default.
• W2573039196 hasConceptScore W2573039196C71924100 @default.
• W2573039196 hasConceptScore W2573039196C98274493 @default.
• W2573039196 hasLocation W25730391961 @default.
• W2573039196 hasOpenAccess W2573039196 @default.
• W2573039196 hasPrimaryLocation W25730391961 @default.
• W2573039196 hasRelatedWork W1955322177 @default.
• W2573039196 hasRelatedWork W2138480544 @default.
• W2573039196 hasRelatedWork W2151181171 @default.
• W2573039196 hasRelatedWork W2360634842 @default.
• W2573039196 hasRelatedWork W2551400370 @default.
• W2573039196 hasRelatedWork W2593968947 @default.
• W2573039196 hasRelatedWork W2753524552 @default.
• W2573039196 hasRelatedWork W3002680405 @default.
• W2573039196 hasRelatedWork W3029317074 @default.
• W2573039196 hasRelatedWork W3174720739 @default.
• W2573039196 isParatext "false" @default.
• W2573039196 isRetracted "false" @default.
• W2573039196 magId "2573039196" @default.
• W2573039196 workType "article" @default.